Results 171 to 180 of about 4,965,169 (312)

Rising Strong: Cultivating Resilience in Edible City Entrepreneurship. Insights Into the Landscape of Urban Food Initiatives

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT In response to growing global challenges, this study explores how social entrepreneurship within the Edible City movement contributes to building resilient, sustainable, and equitable urban food systems. Drawing on semistructured interviews with over 70 stakeholders across five cities—Berlin, Andernach, Oslo, Rotterdam, and Havana—we ...
Ina Säumel   +6 more
wiley   +1 more source

Lessons from the field: implementing pharmacy services in the Tanzanian hospital setting. [PDF]

open access: yesInt Health
Lambert M   +6 more
europepmc   +1 more source

A Prospective, Multicenter, Open Label Study Investigating the Implementation of a Standardized Algorithm for Coronary CaLcificatiOn With PlaquE Modification Using UltraSound Guidance to Improve Procedural and Clinical Outcomes (CYCLOPES): Design and Rationale of the CYCLOPES Trial

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Introduction Moderate‐to‐severe calcification is present in ~20%–30% of patients undergoing coronary angiography. Coronary lesion modification is often necessary to facilitate optimal stent delivery and expansion, with several dedicated devices now approved for calcium modification before stent implantation. The CYCLOPES study aims to evaluate
Daniel O'Callaghan   +14 more
wiley   +1 more source

Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Coronary slow flow (SF) and no‐reflow (NR) are clinically significant complications of percutaneous coronary intervention (PCI), particularly in ST‐segment elevation myocardial infarction (STEMI) and saphenous vein graft (SVG) interventions. Angiographically defined as impaired myocardial perfusion despite restored epicardial patency, SF/NR ...
Bharat Khialani   +5 more
wiley   +1 more source

Scaling surgical care capacity in Nigeria: a narrative review of current practices and innovations in rural surgical workforce development. [PDF]

open access: yesBMC Surg
Uma O   +10 more
europepmc   +1 more source

Left Ventricular Outflow Tract Geometry as a Predictor of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation Using the Evolut Series

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Predicting the need for permanent pacemaker implantation (PPM) after transcatheter aortic valve implantation (TAVI) is crucial for procedural planning and patient counseling. Aims To evaluate whether left ventricular outflow tract (LVOT) morphology, specifically a tapered configuration, predicts conduction disturbances requiring PPM
Mahmoud Abdelshafy   +13 more
wiley   +1 more source

The “Skipping Rope” Technique: A Novel Strategy for Distal Burr Entrapment During Rotational Atherectomy

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We describe the “skipping rope technique” for managing burr entrapment during rotational atherectomy. Sequential counterclockwise rotational force is applied to the drive shaft, generating alternative torque dynamics. This maneuver provides a safe method to disengage a stuck rotaburr, offering operators an additional strategy for this ...
Thomas J. Ford   +3 more
wiley   +1 more source

Oral Hygiene Practices of Hospitalized Patients in Public and Private Hospitals in Al-Ahsa, Saudi Arabia: A Cross-Sectional Study. [PDF]

open access: yesJ Clin Med
Kassem AO   +8 more
europepmc   +1 more source

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy